Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:56am, Wednesday, 15'th Apr 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 13'th Apr 2026
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of “Hold” from Analysts
02:18am, Monday, 13'th Apr 2026
Shares of Novavax, Inc. (NASDAQ: NVAX - Get Free Report) have received an average rating of "Hold" from the ten ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts hav
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
06:46pm, Thursday, 09'th Apr 2026
In the latest trading session, Novavax (NVAX) closed at $8.53, marking a +1.31% move from the previous day.
Novavax Faces Shareholder Revolt As Shah Capital Criticizes Strategy
10:54am, Wednesday, 08'th Apr 2026
The investor, which holds roughly 9% of the company, argued that leadership has failed to translate Novavax's vaccine platform into meaningful commercial success.
Shah Capital intends to vote against Novavax's board nominees, executive compensation
06:08am, Wednesday, 08'th Apr 2026
Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive compensation package at Novavax's upcoming annual meeting, renewing pressure for changes
Traders Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX)
01:25am, Tuesday, 07'th Apr 2026
Novavax, Inc. (NASDAQ: NVAX - Get Free Report) saw some unusual options trading on Monday. Stock investors purchased 21,020 call options on the stock. This is an increase of approximately 71% compared
Novavax (NVAX) Stock Dips While Market Gains: Key Facts
06:45pm, Wednesday, 01'st Apr 2026
In the closing of the recent trading day, Novavax (NVAX) stood at $8.02, denoting a -1.47% move from the preceding trading day.
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving Average – Here’s Why
02:11am, Tuesday, 31'st Mar 2026
Novavax, Inc. (NASDAQ: NVAX - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $8.28 and traded as high as
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
10:45am, Monday, 30'th Mar 2026
The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:00am, Monday, 30'th Mar 2026
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
08:00am, Monday, 30'th Mar 2026
Robert Walker, MD, brings more than 30 years in drug and vaccine development and, most recently, served as Novavax's Chief Medical Officer Dr. Walker will continue advancing Novavax's R&D efforts with
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
06:46pm, Thursday, 26'th Mar 2026
In the most recent trading session, Novavax (NVAX) closed at $8.95, indicating a -4.18% shift from the previous trading day.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Monday, 23'rd Mar 2026
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.
12:49pm, Tuesday, 17'th Mar 2026
The first severe case of the virus has been detected in New York.
